27 October 2008
Oxford Immunotec announces board changes ... more» (PDF)
27 September 2008
Oxford Immunotec announces European approval and launch of T Cell Xtend ... more» (PDF)
01 August 2008
T-SPOT®.TB gains FDA premarket approval ... more» (PDF)
23 May 2008
Study results confirm T-SPOT®.TB is not affected by low CD4 count HIV infected subjects ... more» (PDF)
20 February 2008
Study suggests T-SPOT®.TB response declines with anti-TB treatment ... more» (PDF)
Oxford Immunotec announces board changes ... more» (PDF)
27 September 2008
Oxford Immunotec announces European approval and launch of T Cell Xtend ... more» (PDF)
01 August 2008
T-SPOT®.TB gains FDA premarket approval ... more» (PDF)
23 May 2008
Study results confirm T-SPOT®.TB is not affected by low CD4 count HIV infected subjects ... more» (PDF)
20 February 2008
Study suggests T-SPOT®.TB response declines with anti-TB treatment ... more» (PDF)
